Phibro Animal Health (NASDAQ:PAHC) Shares Down 6.5% – Here’s What Happened

Phibro Animal Health Co. (NASDAQ:PAHC) dropped 6.5% on Wednesday . The company traded as low as $24.11 and last traded at $24.15. Approximately 162,313 shares traded hands during mid-day trading, a decline of 22% from the average daily volume of 207,590 shares. The stock had previously closed at $25.82.

Analysts Set New Price Targets

PAHC has been the subject of a number of recent analyst reports. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays boosted their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Stock Performance

The firm has a market capitalization of $911.25 million, a PE ratio of 46.88, a price-to-earnings-growth ratio of 0.47 and a beta of 0.52. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The business’s 50 day simple moving average is $22.21 and its two-hundred day simple moving average is $22.07.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.13%. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC increased its stake in shares of Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after purchasing an additional 27,201 shares in the last quarter. Barclays PLC increased its stake in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Algert Global LLC increased its stake in shares of Phibro Animal Health by 521.1% in the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after purchasing an additional 59,850 shares in the last quarter. FMR LLC increased its stake in shares of Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after purchasing an additional 7,270 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.